⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24917278 | 0.90 | — | — | |
| SCHEMBL24917279 | 0.90 | — | — | |
| SCHEMBL24917300 | 0.80 | TMPRSS2 (0.32) | — | |
| SCHEMBL24917169 | 0.79 | TMPRSS2 (0.34) | — | |
| SCHEMBL24917170 | 0.77 | TMPRSS2 (0.42) | — | |
| SCHEMBL25909468 | 0.75 | CTSS (0.40) | — | |
| SCHEMBL24916966 | 0.73 | CYP3A4 (0.36) | — | |
| SCHEMBL24917301 | 0.72 | TMPRSS2 (0.32) | — | |
| SCHEMBL24791787 | 0.71 | TMPRSS2 (0.36) | — | |
| SCHEMBL26095113 | 0.71 | TMPRSS2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024722-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. | 2023-01-26 | — | — | US | disclosed |